{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T11:08:01Z","timestamp":1740136081477,"version":"3.37.3"},"reference-count":8,"publisher":"The Endocrine Society","issue":"6","license":[{"start":{"date-parts":[[2023,1,18]],"date-time":"2023-01-18T00:00:00Z","timestamp":1674000000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,5,17]]},"DOI":"10.1210\/clinem\/dgad029","type":"journal-article","created":{"date-parts":[[2023,1,18]],"date-time":"2023-01-18T18:29:22Z","timestamp":1674066562000},"page":"e350-e351","source":"Crossref","is-referenced-by-count":0,"title":["Pheochromocytoma\/Paraganglioma Screening: Low Rates in At-Risk Populations"],"prefix":"10.1210","volume":"108","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2192-554X","authenticated-orcid":false,"given":"Peter","family":"Igaz","sequence":"first","affiliation":[{"name":"Department of Endocrinology, Faculty of Medicine, Semmelweis University , Budapest 1083 , Hungary"},{"name":"Department of Internal Medicine and Oncology, Faculty of Medicine, Semmelweis University , Budapest 1083 , Hungary"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","published-online":{"date-parts":[[2023,1,18]]},"reference":[{"issue":"8","key":"2023051701095552500_dgad029-B1","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1097\/HJH.0000000000002438","article-title":"Genetics, diagnosis, management and future directions of research of phaeochromocytoma and paraganglioma: a position statement and consensus of the Working Group on Endocrine Hypertension of the European Society of Hypertension","volume":"38","author":"Lenders","year":"2020","journal-title":"J Hypertens"},{"issue":"2","key":"2023051701095552500_dgad029-B2","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1530\/EJE-16-0467","article-title":"Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors","volume":"175","author":"Fassnacht","year":"2016","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"2023051701095552500_dgad029-B3","doi-asserted-by":"crossref","first-page":"e343","DOI":"10.1210\/clinem\/dgac701","article-title":"Rates of pheochromocytoma\/paraganglioma screening in at-risk populations","volume":"108","author":"Grigoryan","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2023051701095552500_dgad029-B4","doi-asserted-by":"crossref","first-page":"R51","DOI":"10.1530\/EJE-16-0461","article-title":"MANAGEMENT OF ENDOCRINE DISEASE: imaging for the diagnosis of malignancy in incidentally discovered adrenal masses: a systematic review and meta-analysis","volume":"175","author":"Dinnes","year":"2016","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"2023051701095552500_dgad029-B5","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1210\/jc.2018-01532","article-title":"CT characteristics of pheochromocytoma: relevance for the evaluation of adrenal incidentaloma","volume":"104","author":"Canu","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2023051701095552500_dgad029-B6","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1161\/HYPERTENSIONAHA.119.14359","article-title":"Screening rates for primary aldosteronism in resistant hypertension: a cohort study","volume":"75","author":"Jaffe","year":"2020","journal-title":"Hypertension"},{"issue":"14","key":"2023051701095552500_dgad029-B7","doi-asserted-by":"crossref","first-page":"e025952","DOI":"10.1161\/JAHA.122.025952","article-title":"Primary aldosteronism screening rates differ with sex, race, and comorbidities","volume":"11","author":"Turcu","year":"2022","journal-title":"J Am Heart Assoc"},{"issue":"8","key":"2023051701095552500_dgad029-B8","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1210\/clinem\/dgab348","article-title":"Performance of the aldosterone to renin ratio as a screening test for primary aldosteronism","volume":"106","author":"Hung","year":"2021","journal-title":"J Clin Endocrinol Metab"}],"container-title":["The Journal of Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgad029\/48957019\/dgad029.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/108\/6\/e350\/50355259\/dgad029.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/108\/6\/e350\/50355259\/dgad029.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,17]],"date-time":"2023-05-17T01:11:19Z","timestamp":1684285879000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/108\/6\/e350\/6991392"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,18]]},"references-count":8,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2023,1,18]]},"published-print":{"date-parts":[[2023,5,17]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgad029","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"type":"print","value":"0021-972X"},{"type":"electronic","value":"1945-7197"}],"subject":[],"published-other":{"date-parts":[[2023,6]]},"published":{"date-parts":[[2023,1,18]]}}}